Global Immune Checkpoint Inhibitors Market Research Report 2015-2025

HEY3836608
104 Pages
April 2020
Healthcare

Download Sample Get Discount

Summary

The global Immune Checkpoint Inhibitors market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

PD-1/PD-L1

CTLA-4

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Bristol Myer Squibb

AstraZeneca

Merck & Co.

Roche / Genentech

Incyte Corporation

NewLink Genetics

ArGEN-X

Seattle Genetics

Pfizer

MacroGenics

Celldex Therapeutics

CureTech

Immutep

Innate Pharma

Sorrento Therapeutics

GlaxoSmithKline

GITR, Inc

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Lung Cancer

Colorectal Cancer

Breast Cancer

Prostate Cancer

Melanoma

Blood Cancer

Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

Figure Immune Checkpoint Inhibitors Picture

1.1.2 Specifications

Table Product Specifications of Immune Checkpoint Inhibitors

1.2 Market Segment

1.2.1 by Type

Table Products Segment of Immune Checkpoint Inhibitors

Table Global Immune Checkpoint Inhibitors Market by Type, 2011-2022 (USD Million)

1.2.1.1 PD-1/PD-L1

Table PD-1/PD-L1 Overview

1.2.1.2 CTLA-4

Table CTLA-4 Overview

1.2.2 by Application

Table Application Segment of Immune Checkpoint Inhibitors

Table Global Immune Checkpoint Inhibitors Market by Application, 2011-2022 (USD Million)

1.2.2.1 Lung Cancer

Table Lung Cancer Overview

1.2.2.2 Colorectal Cancer

Table Colorectal Cancer Overview

1.2.2.3 Breast Cancer

Table Breast Cancer Overview

1.2.2.4 Prostate Cancer

Table Prostate Cancer Overview

1.2.2.5 Melanoma

Table Melanoma Overview

1.2.2.6 Blood Cancer

Table Blood Cancer Overview

1.2.2.7 Others

Table Others Overview

1.2.3 by Regions

Table Global Immune Checkpoint Inhibitors Market by Region, 2011-2022 (USD Million)

2 Industry Chain

2.1 Industry Chain Structure

Figure Industry Chain Structure of Immune Checkpoint Inhibitors

2.2 Upstream

Table Cost of Immune Checkpoint Inhibitors

Figure Manufacturing Process of Immune Checkpoint Inhibitors

2.3 Market

2.3.1 SWOT

Figure SWOT of Immune Checkpoint Inhibitors

2.3.2 Dynamics

Table Market Dynamics

3 Environmental Analysis

3.1 Policy

Table Policy of Immune Checkpoint Inhibitors

3.2 Economic

Table GDP of Major Countries

3.3 Technology

Table Technology of Immune Checkpoint Inhibitors

3.4 Market Entry

Table Market Entry of Immune Checkpoint Inhibitors

4 Market Segmentation by Type

4.1 Market Size

4.1.1 PD-1/PD-L1 Market, 2013-2018

Figure PD-1/PD-L1 Market Size and Growth, 2015-2019 (USD Million)

Figure PD-1/PD-L1 Market Size and Growth, 2015-2019 (in Volume)

Table PD-1/PD-L1 CAGR by Revenue and Volume, 2015-2019

4.1.2 CTLA-4 Market, 2013-2018

Figure CTLA-4 Market Size and Growth, 2015-2019 (USD Million)

Figure CTLA-4 Market Size and Growth, 2015-2019 (in Volume)

Table CTLA-4 CAGR by Revenue and Volume, 2015-2019

4.2 Market Forecast

4.2.1 PD-1/PD-L1 Market Forecast, 2020-2025

Figure PD-1/PD-L1 Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure PD-1/PD-L1 Market Estimates and Forecasts, 2020-2025 (in Volume)

Table PD-1/PD-L1 CAGR by Revenue and Volume, 2012-2024

4.2.2 CTLA-4 Market Forecast, 2020-2025

Figure CTLA-4 Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure CTLA-4 Market Estimates and Forecasts, 2020-2025 (in Volume)

Table CTLA-4 CAGR by Revenue and Volume, 2012-2024

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Lung Cancer Market, 2013-2018

Figure Lung Cancer Market Size and Growth, 2015-2019 (USD Million)